Suppr超能文献

衡量心脏病监测的成本与效益。

Measuring the costs and benefits of heart disease monitoring.

作者信息

Perry A, Capewell S, Walker A, Chalmers J, Redpath A, Major K, Morrison C E, Craig N, Cobbe S, Smith W C

机构信息

Department of Public Health, University of Glasgow, Glasgow 12, UK.

出版信息

Heart. 2000 Jun;83(6):651-6. doi: 10.1136/heart.83.6.651.

Abstract

OBJECTIVE

To evaluate the costs and benefits of alternative systems of coronary heart disease monitoring in Scotland.

DESIGN

An option appraisal was conducted to evaluate the costs and benefits of implementing a coronary heart disease monitoring system. This involved a review of existing Scottish datasets and relevant reports, specification of options, definition and weighting of benefit criteria by key stakeholders, assessment of options by experts, and costing of options. The options were assessed by 33 stakeholders (grouped as cardiologists, patient representatives, general practitioners, public health physicians, and policy makers), plus 13 topic experts.

SETTING

Scotland (population 5.1 million).

RESULTS

Between group mean benefit weights were: mortality rates and case fatality (10.6), quality of life (9.8), patient function (8.8), hospital activity (7.8), primary care activity (9.25), prescribing (5.72), socioeconomic impact (4.0), risk factors (7.4), prevalence (5.0), incidence (6.0), case registration (6.82), international comparability (4.2), breadth of coverage (8.8), and frequency (5.8). Differences between group weights were significant for prevalence (p = 0.048) and international comparability (p = 0.032). Four monitoring options were identified: a community epidemiology model, based on MONICA (monitoring trends and determinants in cardiovascular disease) study methodology applied to a series of eight representative communities, had the highest benefits, at an average annual discounted cost of approximately pound 360,000; models based on the Australian cardiovascular disease monitoring scheme and on enhanced routine data offered fewer benefits at discounted average annual costs ranging from pound 165,000 to pound 195,000; finally, a coronary heart disease registry modelled on the Scottish Cancer Registry scheme would have had fewer benefits and substantially higher costs than the other options.

CONCLUSIONS

The most beneficial coronary heart disease monitoring system is the community epidemiology model, based on MONICA methodology. Option appraisal potentially offers an explicit and transparent methodology for evidence based policy development.

摘要

目的

评估苏格兰冠心病监测替代系统的成本与效益。

设计

进行了一项方案评估,以评估实施冠心病监测系统的成本与效益。这包括对苏格兰现有数据集和相关报告的审查、方案的详细说明、关键利益相关者对效益标准的定义和加权、专家对方案的评估以及方案的成本核算。33名利益相关者(分为心脏病专家、患者代表、全科医生、公共卫生医生和政策制定者)以及13名主题专家对这些方案进行了评估。

地点

苏格兰(人口510万)。

结果

组间平均效益权重分别为:死亡率和病死率(10.6)、生活质量(9.8)、患者功能(8.8)、医院活动(7.8)、初级保健活动(9.25)、处方(5.72)、社会经济影响(4.0)、危险因素(7.4)、患病率(5.0)、发病率(6.0)、病例登记(6.82)、国际可比性(4.2)、覆盖范围广度(8.8)和频率(5.8)。组间权重在患病率(p = 0.048)和国际可比性(p = 0.032)方面存在显著差异。确定了四种监测方案:一种基于MONICA(心血管疾病监测趋势和决定因素)研究方法应用于一系列八个代表性社区的社区流行病学模型,效益最高,平均每年贴现成本约为360,000英镑;基于澳大利亚心血管疾病监测方案和强化常规数据的模型效益较少,平均每年贴现成本在165,000英镑至195,000英镑之间;最后,以苏格兰癌症登记方案为蓝本的冠心病登记系统效益比其他方案少,成本却大幅高于其他方案。

结论

最有益的冠心病监测系统是基于MONICA方法的社区流行病学模型。方案评估可能为基于证据的政策制定提供一种明确且透明的方法。

相似文献

引用本文的文献

本文引用的文献

1
An approach to longitudinal studies in a community: the Framingham Study.
Ann N Y Acad Sci. 1963 May 22;107:539-56. doi: 10.1111/j.1749-6632.1963.tb13299.x.
2
What value do computers provide to NHS hospitals?
BMJ. 1996 Jun 1;312(7043):1407-10.
3
4
Design and analysis of community trials: lessons from the Minnesota Heart Health Program.
Am J Epidemiol. 1995 Sep 15;142(6):569-75. doi: 10.1093/oxfordjournals.aje.a117677.
5
The Stanford Five-City Project: design and methods.
Am J Epidemiol. 1985 Aug;122(2):323-34. doi: 10.1093/oxfordjournals.aje.a114104.
8
Registering a need.
BMJ. 1992 Sep 12;305(6854):597-8. doi: 10.1136/bmj.305.6854.597.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验